Insider Trading
Current insider transactions (SEC Form 4) — buys and sells by officers, directors, and major shareholders.
| Ticker | Insider | Title | Date | Transaction | Price ($) | Shares | Value ($) | SEC Form 4 |
|---|---|---|---|---|---|---|---|---|
| OKLO | DeWitte Jacob | Co-Founder, CEO | 08/03/2026 | Verkauf | 40.14 | 12,849 | 515,759 | Form 4 |
| OKLO | DeWitte Jacob | Co-Founder, CEO | 08/03/2026 | Verkauf | 41.35 | 40,000 | 1,654,000 | Form 4 |
| OKLO | Bealmear Richard Craig | Chief Financial Officer | 08/03/2026 | Verkauf | 38.80 | 16,452 | 638,338 | Form 4 |
| NTRA | Fesko John | PRESIDENT, CHIEF BUS. OFFICER | 08/03/2026 | Verkauf | 267.99 | 295 | 79,057 | Form 4 |
| NTRA | Moshkevich Solomon | PRESIDENT, CLINICALDIAGNOSTICS | 08/03/2026 | Verkauf | 268.70 | 128 | 34,393 | Form 4 |
| NTRA | Moshkevich Solomon | PRESIDENT, CLINICALDIAGNOSTICS | 08/03/2026 | Verkauf | 267.79 | 1,233 | 330,181 | Form 4 |
| NTRA | Moshkevich Solomon | PRESIDENT, CLINICALDIAGNOSTICS | 08/03/2026 | Verkauf | 265.28 | 192 | 50,933 | Form 4 |
| NTRA | Moshkevich Solomon | PRESIDENT, CLINICALDIAGNOSTICS | 08/03/2026 | Verkauf | 263.94 | 947 | 249,953 | Form 4 |
| NTRA | Moshkevich Solomon | PRESIDENT, CLINICALDIAGNOSTICS | 08/03/2026 | Verkauf | 261.49 | 200 | 52,298 | Form 4 |
| NTRA | Moshkevich Solomon | PRESIDENT, CLINICALDIAGNOSTICS | 08/03/2026 | Verkauf | 259.98 | 300 | 77,994 | Form 4 |
| NTRA | Moshkevich Solomon | PRESIDENT, CLINICALDIAGNOSTICS | 08/03/2026 | Verkauf | 267.99 | 410 | 109,876 | Form 4 |
| NTRA | Rabinowitz Daniel | SEC. AND CHIEF LEGAL OFFICER | 08/03/2026 | Verkauf | 267.99 | 334 | 89,508 | Form 4 |
| NTRA | Chapman Steven Leonard | CEO AND PRESIDENT | 08/03/2026 | Verkauf | 268.22 | 612 | 164,150 | Form 4 |
| NTRA | Chapman Steven Leonard | CEO AND PRESIDENT | 08/03/2026 | Verkauf | 267.08 | 296 | 79,057 | Form 4 |
| NTRA | Chapman Steven Leonard | CEO AND PRESIDENT | 08/03/2026 | Verkauf | 265.27 | 80 | 21,222 | Form 4 |
| NTRA | Chapman Steven Leonard | CEO AND PRESIDENT | 08/03/2026 | Verkauf | 263.86 | 676 | 178,371 | Form 4 |
| NTRA | Chapman Steven Leonard | CEO AND PRESIDENT | 08/03/2026 | Verkauf | 261.03 | 70 | 18,272 | Form 4 |
| NTRA | Chapman Steven Leonard | CEO AND PRESIDENT | 08/03/2026 | Verkauf | 259.98 | 160 | 41,597 | Form 4 |
| NTRA | Chapman Steven Leonard | CEO AND PRESIDENT | 08/03/2026 | Verkauf | 267.99 | 1,182 | 316,763 | Form 4 |
| NTRA | Brophy Michael Burkes | CHIEF FINANCIAL OFFICER | 08/03/2026 | Verkauf | 267.99 | 317 | 84,953 | Form 4 |
| NTRA | Sheena Jonathan | Director | 08/03/2026 | Verkauf | 267.99 | 109 | 29,211 | Form 4 |
| NTRA | Rabinowitz Matthew | EXECUTIVE CHAIRMAN | 08/03/2026 | Verkauf | 267.99 | 731 | 195,900 | Form 4 |
| NUE | Batterbee Thomas J. | Executive Vice President | 08/03/2026 | Verkauf | 261.02 | 4,000 | 1,044,062 | Form 4 |
| NPB | Hooker David Stevens | Director | 08/03/2026 | Verkauf | 17.59 | 214 | 3,765 | Form 4 |
| NPB | Hooker David Stevens | Director | 08/03/2026 | Verkauf | 17.59 | 2,995 | 52,692 | Form 4 |
| NMIH | Smith Robert Owen | EVP, Chief Risk Officer | 08/03/2026 | Verkauf | 44.65 | 12,000 | 535,763 | Form 4 |
| NEM | Toth Peter | EVP, Chief Sustain & Dev Off | 08/03/2026 | Verkauf | 93.45 | 3,000 | 280,350 | Form 4 |
| NDAQ | Smith Bryan Everard | EVP, CPO | 08/03/2026 | Verkauf | 95.07 | 1,556 | 147,929 | Form 4 |
| MORN | Mansueto Joseph D | Executive Chairman | 08/03/2026 | Verkauf | 200.87 | 26 | 5,223 | Form 4 |
| MORN | Mansueto Joseph D | Executive Chairman | 08/03/2026 | Verkauf | 199.78 | 2,568 | 513,023 | Form 4 |
| MORN | Mansueto Joseph D | Executive Chairman | 08/03/2026 | Verkauf | 199.06 | 4,043 | 804,806 | Form 4 |
| MORN | Mansueto Joseph D | Executive Chairman | 08/03/2026 | Verkauf | 197.72 | 573 | 113,296 | Form 4 |
| MORN | Mansueto Joseph D | Executive Chairman | 08/03/2026 | Verkauf | 196.72 | 40 | 7,869 | Form 4 |
| MIRM | Howe Jolanda | SVP, GLOBAL CONTROLLER | 08/03/2026 | Verkauf | 105.29 | 1,840 | 193,734 | Form 4 |
| META | Kimmitt Robert M | Director | 08/03/2026 | Verkauf | 561.56 | 500 | 280,780 | Form 4 |
| MAX | Nonko Eugene | Director | 08/03/2026 | Verkauf | 12.48 | 8,205 | 102,423 | Form 4 |
| MAX | Nonko Eugene | Director | 08/03/2026 | Verkauf | 12.54 | 3,282 | 41,157 | Form 4 |
| MAX | Yi Steven | See Remarks | 08/03/2026 | Verkauf | 12.64 | 72,000 | 909,994 | Form 4 |
| MAZE | Coloma Jason V | Chief Executive Officer | 08/03/2026 | Verkauf | 27.09 | 1,604 | 43,445 | Form 4 |
| MAZE | Coloma Jason V | Chief Executive Officer | 08/03/2026 | Verkauf | 26.71 | 30,304 | 809,541 | Form 4 |
| MAZE | Coloma Jason V | Chief Executive Officer | 08/03/2026 | Verkauf | 27.09 | 154 | 4,172 | Form 4 |
| MAZE | Coloma Jason V | Chief Executive Officer | 08/03/2026 | Verkauf | 26.71 | 2,439 | 65,157 | Form 4 |
| MPWR | Sciammas Maurice | EVP, WW Sales & Marketing | 08/03/2026 | Verkauf | 1,343.94 | 30 | 40,318 | Form 4 |
| MHK | Helen Suzanne L | Possible Member of Group | 08/03/2026 | Verkauf | 131.52 | 7,000 | 920,640 | Form 4 |
| MHK | Lorberbaum Jeffrey S | CHIEF EXECUTIVE OFFICER | 08/03/2026 | Verkauf | 132.91 | 2,116 | 281,238 | Form 4 |
| MHK | Lorberbaum Jeffrey S | CHIEF EXECUTIVE OFFICER | 08/03/2026 | Verkauf | 132.03 | 935 | 123,448 | Form 4 |
| MHK | Lorberbaum Jeffrey S | CHIEF EXECUTIVE OFFICER | 08/03/2026 | Verkauf | 130.99 | 1,918 | 251,239 | Form 4 |
| MHK | Lorberbaum Jeffrey S | CHIEF EXECUTIVE OFFICER | 08/03/2026 | Verkauf | 130.26 | 795 | 103,557 | Form 4 |
| MHK | Lorberbaum Jeffrey S | CHIEF EXECUTIVE OFFICER | 08/03/2026 | Verkauf | 132.91 | 6,877 | 914,022 | Form 4 |
| MHK | Lorberbaum Jeffrey S | CHIEF EXECUTIVE OFFICER | 08/03/2026 | Verkauf | 132.03 | 3,038 | 401,107 | Form 4 |
| MHK | Lorberbaum Jeffrey S | CHIEF EXECUTIVE OFFICER | 08/03/2026 | Verkauf | 130.99 | 6,233 | 816,461 | Form 4 |
| MHK | Lorberbaum Jeffrey S | CHIEF EXECUTIVE OFFICER | 08/03/2026 | Verkauf | 130.26 | 2,585 | 336,722 | Form 4 |
| MHK | Lorberbaum Jeffrey S | CHIEF EXECUTIVE OFFICER | 08/03/2026 | Verkauf | 132.91 | 9,024 | 1,199,380 | Form 4 |
| MHK | Lorberbaum Jeffrey S | CHIEF EXECUTIVE OFFICER | 08/03/2026 | Verkauf | 132.03 | 3,986 | 526,272 | Form 4 |
| MHK | Lorberbaum Jeffrey S | CHIEF EXECUTIVE OFFICER | 08/03/2026 | Verkauf | 130.99 | 8,179 | 1,071,367 | Form 4 |
| MHK | Lorberbaum Jeffrey S | CHIEF EXECUTIVE OFFICER | 08/03/2026 | Verkauf | 130.26 | 3,392 | 441,842 | Form 4 |
| MHK | Lorberbaum Jeffrey S | CHIEF EXECUTIVE OFFICER | 08/03/2026 | Verkauf | 131.33 | 280 | 36,772 | Form 4 |
| MHK | Lorberbaum Jeffrey S | CHIEF EXECUTIVE OFFICER | 08/03/2026 | Verkauf | 130.70 | 9,720 | 1,270,404 | Form 4 |
| MTD | Salice Thomas P | Director | 08/03/2026 | Verkauf | 1,444.62 | 415 | 599,517 | Form 4 |
| MTD | Keller Gerry | Head of Process Analytics | 08/03/2026 | Verkauf | 1,427.14 | 240 | 342,514 | Form 4 |
A compact market overview — not investment advice. Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q).